PATENT CLAIM ANALYSIS

Application Number: 16247132
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 5  are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 12):
A method for the treatment or prophylaxis of hepatitis B virus infection, which method comprises administering a therapeutically effective amount of a compound as defined in  claim 1 .

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.28205
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14997346', '16247170', '16196324', '16247084', '14632078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8036797162357106
- 35 USC 102 Novelty (BERT): 0.5823142203016485
- Combined Prediction Score: 0.7815431666423044
- Mean Citation Score: 415.54647000000006
- Max Citation Score: 473.76462
- Similarity Product: 434.6787090234804

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test